A Phase III Study Comparing HRS-4357 With Novel Androgen Receptor Pathway Inhibitors in Patients With Progressive, PSMA-Positive Metastatic Castration-Resistant Prostate Cancer
Clinical trial NCT07311694 · RECRUITING
Trial details
- NCT number
- NCT07311694
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-02
- Primary completion
- 2027-12-01
- Enrollment
- 370
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.